Active Ingredient: BUPRENORPHINE HYDROCHLORIDE
Proprietary Name: SUBUTEX
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020732
Product Number: 002
Approval Date: Oct 8, 2002
Applicant Holder Full Name: INDIVIOR INC
Marketing Status:
Discontinued
Patent and Exclusivity Information